Top analysts just can’t get enough of these three hot stocks.

TipRanks’ nifty Trending Stocks tool enables you to quickly pinpoint the best-rated stocks out there. This can be over the last 72 hours, 1 week or 1 month. Here we used a 1-month period and looked for the most compelling stocks from all sectors, with a market cap above $5 billion. These three stocks have all received multiple Buy ratings from analysts over the last few days. Plus the upside potential from current levels looks promising, as we can see below:

Why are analysts so bullish? Let’s take a closer look at these three stocks now.

1. Alnylam Pharma (Nasdaq: ALNY)

Welcome to the best-rated trending stock of the last 30 days. Nine analysts have published Buy ratings on Alnylam Pharmaceuticals, Inc. in the last week. That’s with an average price target of $167.75- indicating over 80% upside potential.

Alnylam Pharma is developing novel RNAi-based therapies to treat a wide range of debilitating diseases. This includes TTR amyloid disease- a rare and potentially fatal protein buildup.

Five-star Madhu Kumar (Profile & Recommendations) has just reiterated his ALNY Buy rating, $210 price target, and Alnylam’s status as an Out-the-Gate 2018 stock pick. He recommends the stock ahead of crunch-date August 11. This is when the FDA will either approve or reject ALNY’s lead asset Onpattro.

“We continue to have conviction that ALNY’s transthyretin (TTR) RNAi franchise should dominate the landscape of hereditary TTR amyloidosis (hATTR), with the August 11, 2018, PDUFA date for lead asset Onpattro potentially serving as a positive catalyst for ALNY shares.”

Here we can see the stock’s outlook from only best-performing analysts:

View ALNY Price Target & Analyst Rating Details

2. Activision Blizzard (Nasdaq: ATVI)

Game on! So says top Jefferies analyst Timothy O’Shea (Profile & Recommendations). He has just selected Activision Blizzard as his No. 1 Franchise Pick with a bullish $86 price target (22% upside potential).